Minority Institutions' Drug Abuse Research Development Program (MIDARP)

The summary for the Minority Institutions' Drug Abuse Research Development Program (MIDARP) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Minority Institutions' Drug Abuse Research Development Program (MIDARP): The National Institute on Drug Abuse, NIH, is providing support to increase research capacity of minority institutions to conduct research in drug abuse and addiction. Grants will be provided to foster research career development of racial/ethnic minority faculty, students and staff who are underrepresented in drug abuse research, and to enhance research infrastructure at minority institutions.

Federal Grant Title:	Minority Institutions' Drug Abuse Research Development Program (MIDARP)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-05-069
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse Research Programs
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Mar 15, 2005
Creation Date:	Mar 30, 2007
Archive Date:	Oct 08, 2008
Total Program Funding:
Maximum Federal Grant Award:	$350,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Institutions applying for this award must demonstrate eligibility through (a) minority designation or (b) minority status and research capacity development need. Applications may be submitted by an organization, university or college that meets one of the following criteria regarding minority classification: (a) A public or private nonprofit university, four-year college, or other institution offering undergraduate or graduate degrees with a traditionally high (more than 50 percent) minority (Black, Hispanic, Native American or Alaskan Native, Asian or Pacific Islander) student enrollment. This category of minority designated institutions comprises Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions (HSIs), and Tribal Colleges. An Indian tribe, which in conjunction with one or more institutions of higher learning, offers undergraduate and graduate degrees in disciplines relevant to drug abuse, which has a recognized governing body, and which performs substantial governmental functions, or an Alaska Regional Corporation (ARC) as defined in the Alaska Native Claims Settlement Act (43 U.S.C. 1601 et seq.) is eligible. (b) A college or university with an under-represented minority student enrollment of at least 25% in each of the previous five years. In addition, these minority status applicants must demonstrate commitment to under-represented minority research development goals through (a) evidence of efforts to recruit faculty and students who are members of minorities nationally underrepresented in behavioral and biomedical research, and (b) demonstration of efforts to provide research support and resources to underrepresented minority faculty and students. Applications must indicate which of the above two eligibility conditions applies to the institution and provide documentation in support of the eligibility claim. (See APPLICATION PROCEDURES, below.) Foreign institutions are not eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...; • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...; • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...; • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)